Total efficacy ra,tes for single symptom of IBS were as follows: abdominal pain 85.1% (40/47), diarrhea 89.2% (33/37) and constipation 93.3% (14/15). The global efficacy rate for IBS was 85.1% (40/47).

• 得舒特对肠易激综合征患者腹痛、腹泻和便秘单项症状的有效率分别为85.；1%25(40/47)、89